Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
International Journal of Oncology
Join Editorial Board Propose a Special Issue
Print ISSN: 1019-6439 Online ISSN: 1791-2423
Journal Cover
October-2026 Volume 69 Issue 4

Full Size Image

Cover Legend PDF

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
October-2026 Volume 69 Issue 4

Full Size Image

Cover Legend PDF

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Correction Open Access

[Corrigendum] Sulforaphane reduces molecular response to hypoxia in ovarian tumor cells independently of their resistance to chemotherapy

  • Authors:
    • Michal Pastorek
    • Veronika Simko
    • Martina Takacova
    • Monika Barathova
    • Maria Bartosova
    • Luba Hunakova
    • Olga Sedlakova
    • Sona Hudecova
    • Olga Krizanova
    • Franck Dequiedt
    • Silvia Pastorekova
    • Jan Sedlak
  • View Affiliations / Copyright

    Affiliations: Laboratory of Tumor Immunology, Cancer Research Institute, Slovak Academy of Sciences, 833 91 Bratislava, Slovak Republic, Institute of Virology, Slovak Academy of Sciences, 833 91 Bratislava, Slovak Republic, Institute of Molecular Physiology and Genetics, Slovak Academy of Sciences, 833 91 Bratislava, Slovak Republic, Laboratory of Protein Signaling and Interactions, Interdisciplinary Cluster for Applied Genoproteomics, University of Liège, Sart-Tilman, Belgium
    Copyright: © Pastorek et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
  • Article Number: 118
    |
    Published online on: August 20, 2026
       https://doi.org/10.3892/ijo.2026.5931
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:


Article

Int J Oncol 47: [Related article:] 51-60, 2015; DOI: 10.3892/ijo.2015.2987

Following the publication of the above article, an interested reader drew to the Editor's attention that the β-actin control protein band featured in the right-hand lane of Fig. 1A on p. 54 appeared to be strikingly similar to the β-actin control protein band featured in the right-hand lane of Fig. 2B on the same page, albeit after vertical flipping and with possible horizontal and vertical resizing. Owing to the lack of availability of the raw western blot data due to the time that has elapsed since this paper was published, the authors have repeated the experiments and provided new western blots for these figures, which fully confirm the veracity of the findings presented in the originally published study. The revised versions of Figs. 1 and 2 are shown on the next page.

Molecular and cellular response of
A2780 cells to hypoxia and SFN. (A) Western blot analysis of HIF-1α
and CA IX expression in A2780 cells. The blot shows that these
proteins are absent in normoxia (No) but induced in response to
hypoxia (Hy). Actin serves as a loading control. (B) Flow
cytometric analysis of the viability of hypoxic vs. normoxic A2780
cells (control) and the parallel normoxic vs. hypoxic samples
treated with increasing concentrations of SFN as described in
Materials and methods. The graph depicting percentage of live
(propidium iodide-negative) cells in population indicates only
insignificant decrease in cell viability in all treated samples.
(C) Real-time analysis of proliferation of the hypoxic A2780 cells
treated with 5 μM SFN for 48 h compared with the non-treated
controls. The graph shows the slope of cell index normalized to 6 h
time point after plating at which time all cells were attached to
the bottom of the wells of the impedance plate and hypoxia was
settled at 2%. Data indicate that SFN treatment did not affect the
proliferation of hypoxic A2780 cells. (D) Cell-based dual
luciferase reporter assay of hypoxic vs. normoxic A2780 cells and
hypoxic A2780 cells vs. cells treated with 5 μM SFN revealed
hypoxia- and SFN-induced alterations of several signal transduction
pathways leading to changes in transactivation activities of the
transcription factors indicated in the graph. In principle, SFN
downregulated pro-oncogenic pathways (represented by HIF-1α and
AP-1) and upregulated anti-oncogenic pathways (such as ARE/NRF2,
p53, IRF-1, Pax-6 and XRE).

Figure 1

Molecular and cellular response of A2780 cells to hypoxia and SFN. (A) Western blot analysis of HIF-1α and CA IX expression in A2780 cells. The blot shows that these proteins are absent in normoxia (No) but induced in response to hypoxia (Hy). Actin serves as a loading control. (B) Flow cytometric analysis of the viability of hypoxic vs. normoxic A2780 cells (control) and the parallel normoxic vs. hypoxic samples treated with increasing concentrations of SFN as described in Materials and methods. The graph depicting percentage of live (propidium iodide-negative) cells in population indicates only insignificant decrease in cell viability in all treated samples. (C) Real-time analysis of proliferation of the hypoxic A2780 cells treated with 5 μM SFN for 48 h compared with the non-treated controls. The graph shows the slope of cell index normalized to 6 h time point after plating at which time all cells were attached to the bottom of the wells of the impedance plate and hypoxia was settled at 2%. Data indicate that SFN treatment did not affect the proliferation of hypoxic A2780 cells. (D) Cell-based dual luciferase reporter assay of hypoxic vs. normoxic A2780 cells and hypoxic A2780 cells vs. cells treated with 5 μM SFN revealed hypoxia- and SFN-induced alterations of several signal transduction pathways leading to changes in transactivation activities of the transcription factors indicated in the graph. In principle, SFN downregulated pro-oncogenic pathways (represented by HIF-1α and AP-1) and upregulated anti-oncogenic pathways (such as ARE/NRF2, p53, IRF-1, Pax-6 and XRE).

Effect of SFN on HIF-1α transcription,
protein level and stability in A2780 cells. (A)
Reverse-transcription PCR analysis of the HIF-1α transcription in
normoxic and hypoxic A2780 cells in the absence and the presence of
SFN. β-actin was used as standard. SFN treatment did not change the
levels of the HIF-1α transcript. (B) Western blot analysis of
HIF-1α protein levels in non-treated hypoxic A2780 cells (Hy) and
in hypoxic A2780 cells treated with 5 μM SFN (Hy+SFN). (C) Western
blot analysis of HIF-1α protein stability in non-treated (Hypoxia)
and in 5 μM SFN-treated hypoxic A2780 cells (Hypoxia+SFN) in the
presence of 20 μg/ml cycloheximide (CHX). SFN treatment did not
affect the HIF-1α level suggesting that it did not decrease the
HIF-1α protein stability.versus control cells.

Figure 2

Effect of SFN on HIF-1α transcription, protein level and stability in A2780 cells. (A) Reverse-transcription PCR analysis of the HIF-1α transcription in normoxic and hypoxic A2780 cells in the absence and the presence of SFN. β-actin was used as standard. SFN treatment did not change the levels of the HIF-1α transcript. (B) Western blot analysis of HIF-1α protein levels in non-treated hypoxic A2780 cells (Hy) and in hypoxic A2780 cells treated with 5 μM SFN (Hy+SFN). (C) Western blot analysis of HIF-1α protein stability in non-treated (Hypoxia) and in 5 μM SFN-treated hypoxic A2780 cells (Hypoxia+SFN) in the presence of 20 μg/ml cycloheximide (CHX). SFN treatment did not affect the HIF-1α level suggesting that it did not decrease the HIF-1α protein stability.versus control cells.

In response to an additional query, the authors also wished to point out that the raw data from the PCR analysis (which were presented to the Editorial Office for inspection) confirmed that the data were correctly assembled from the original electropherograms, and that the part of Fig. 4C associated with the A2780/ADR cells was composed of two parts that came from the same experiment and the same run. They were put together as such, simply because they were loaded in two separate parts of the gel. The authors thank the Editor of International Journal of Oncology for granting them the opportunity to publish this corrigendum. All the authors agree with the publication of this corrigendum; furthermore, they apologize to the readership of the journal for any inconvenience caused.

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Pastorek M, Simko V, Takacova M, Barathova M, Bartosova M, Hunakova L, Sedlakova O, Hudecova S, Krizanova O, Dequiedt F, Dequiedt F, et al: [Corrigendum] Sulforaphane reduces molecular response to hypoxia in ovarian tumor cells independently of their resistance to chemotherapy. Int J Oncol 69: 118, 2026.
APA
Pastorek, M., Simko, V., Takacova, M., Barathova, M., Bartosova, M., Hunakova, L. ... Sedlak, J. (2026). [Corrigendum] Sulforaphane reduces molecular response to hypoxia in ovarian tumor cells independently of their resistance to chemotherapy. International Journal of Oncology, 69, 118. https://doi.org/10.3892/ijo.2026.5931
MLA
Pastorek, M., Simko, V., Takacova, M., Barathova, M., Bartosova, M., Hunakova, L., Sedlakova, O., Hudecova, S., Krizanova, O., Dequiedt, F., Pastorekova, S., Sedlak, J."[Corrigendum] Sulforaphane reduces molecular response to hypoxia in ovarian tumor cells independently of their resistance to chemotherapy". International Journal of Oncology 69.4 (2026): 118.
Chicago
Pastorek, M., Simko, V., Takacova, M., Barathova, M., Bartosova, M., Hunakova, L., Sedlakova, O., Hudecova, S., Krizanova, O., Dequiedt, F., Pastorekova, S., Sedlak, J."[Corrigendum] Sulforaphane reduces molecular response to hypoxia in ovarian tumor cells independently of their resistance to chemotherapy". International Journal of Oncology 69, no. 4 (2026): 118. https://doi.org/10.3892/ijo.2026.5931
Copy and paste a formatted citation
x
Spandidos Publications style
Pastorek M, Simko V, Takacova M, Barathova M, Bartosova M, Hunakova L, Sedlakova O, Hudecova S, Krizanova O, Dequiedt F, Dequiedt F, et al: [Corrigendum] Sulforaphane reduces molecular response to hypoxia in ovarian tumor cells independently of their resistance to chemotherapy. Int J Oncol 69: 118, 2026.
APA
Pastorek, M., Simko, V., Takacova, M., Barathova, M., Bartosova, M., Hunakova, L. ... Sedlak, J. (2026). [Corrigendum] Sulforaphane reduces molecular response to hypoxia in ovarian tumor cells independently of their resistance to chemotherapy. International Journal of Oncology, 69, 118. https://doi.org/10.3892/ijo.2026.5931
MLA
Pastorek, M., Simko, V., Takacova, M., Barathova, M., Bartosova, M., Hunakova, L., Sedlakova, O., Hudecova, S., Krizanova, O., Dequiedt, F., Pastorekova, S., Sedlak, J."[Corrigendum] Sulforaphane reduces molecular response to hypoxia in ovarian tumor cells independently of their resistance to chemotherapy". International Journal of Oncology 69.4 (2026): 118.
Chicago
Pastorek, M., Simko, V., Takacova, M., Barathova, M., Bartosova, M., Hunakova, L., Sedlakova, O., Hudecova, S., Krizanova, O., Dequiedt, F., Pastorekova, S., Sedlak, J."[Corrigendum] Sulforaphane reduces molecular response to hypoxia in ovarian tumor cells independently of their resistance to chemotherapy". International Journal of Oncology 69, no. 4 (2026): 118. https://doi.org/10.3892/ijo.2026.5931
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team